Press releases

(July 1, 2005) -- Boston Scientific Corporation (NYSE: BSX) announced today that a U.S. District Court jury in Delaware found that Johnson & Johnson's (NYSE: JNJ) CYPHER® drug-eluting stent...

(June 27, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that it is voluntarily recalling worldwide all Hemashield® VANTAGE™ Vascular Grafts, which are used in peripheral...

(June 24, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that it has entered into a civil settlement agreement with the U.S. Department of Justice regarding the Department's...

(June 21, 2005) -- Boston Scientific Corporation (NYSE: BSX) announced today that a jury in a patent infringement case in U.S. District Court in Delaware brought by Johnson & Johnson (NYSE: JNJ)...

(June 20, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that it has completed enrollment in the transitional phase of the world's largest drug-eluting stent registry. The...

(June 14, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that it has completed the final phase of the acquisition of Rubicon Medical Corporation (OTC BB: RMDC). Boston...

(June 9, 2005) -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in Goldman Sachs' 25th Annual Healthcare Conference, which is being held June 13 -16 in Dana Point, CA....

(June 9, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that a Dutch court has ruled that Cordis Europa N.V. ("Cordis"), a subsidiary of Johnson & Johnson (NYSE: JNJ),...

(June 2, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced the completion of the cash tender offer for any and all outstanding shares of common stock of Rubicon Medical...

(June 1, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced that Lucia Luce Quinn has been appointed Executive Vice President of Human Resources. She will be responsible for...